Advertisement
Skip to Content

T. Rowe Price Health Sciences PRHSX

Analyst rating as of
  • NAV / 1-Day Return 90.39  /  0.38 %
  • Total Assets 16.2 Bil
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.00
  • Turnover 34%

Morningstar’s Analysis PRHSX

Will PRHSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Offers an edge in the healthcare sector.

Senior Analyst

Summary

|

T. Rowe Price Health Sciences has the expertise and structure it needs to add value in this rapidly evolving market segment, resulting in a Morningstar Analyst Rating of Silver.

Unlock our full analysis with Morningstar Investor